HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,571,842 | +48.3% | 134,617 | +31.8% | 0.01% | +42.9% |
| Q2 2023 | $10,501,489 | -94.5% | 102,100 | -94.1% | 0.01% | -94.4% |
| Q1 2023 | $189,726,568 | -57.8% | 1,738,146 | -56.0% | 0.12% | -61.1% |
| Q4 2022 | $449,447,439 | +20.2% | 3,949,519 | -67.3% | 0.32% | +14.6% |
| Q3 2022 | $374,005,632 | -36.9% | 12,074,036 | +62.4% | 0.28% | -31.5% |
| Q2 2022 | $593,181,000 | -21.3% | 7,436,610 | +3.8% | 0.41% | +12.4% |
| Q1 2022 | $754,114,000 | -0.8% | 7,167,617 | +1.6% | 0.36% | +14.8% |
| Q4 2021 | $759,951,000 | +14.6% | 7,052,188 | +16.5% | 0.32% | +9.3% |
| Q3 2021 | $663,123,000 | +21.6% | 6,053,732 | +3.9% | 0.29% | +24.5% |
| Q2 2021 | $545,382,000 | -22.0% | 5,824,194 | -23.3% | 0.23% | -27.0% |
| Q1 2021 | $699,243,000 | +16.7% | 7,597,157 | -7.3% | 0.32% | +14.7% |
| Q4 2020 | $599,294,000 | -13.7% | 8,192,621 | -8.3% | 0.28% | -23.2% |
| Q3 2020 | $694,317,000 | +49.5% | 8,938,153 | +6.9% | 0.36% | +38.7% |
| Q2 2020 | $464,509,000 | +134.7% | 8,357,524 | +25.1% | 0.26% | +91.9% |
| Q1 2020 | $197,948,000 | -6.9% | 6,682,922 | +13.7% | 0.14% | +24.8% |
| Q4 2019 | $212,697,000 | – | 5,875,619 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |